Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

Posted by Leanne Kodsman on

Innovative Research's Human Complement was recently used in the following study:

Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica

L Tradtrantip, X Yao, T Su, AJ Smith, AS Verkman - Acta Neuropathologica, 2017 ... Complement dependent cytotoxicity Specified concentrations of AQP4-IgG (or control human IgG, Thermo Fisher Scientific, Rockford, IL) and human complement (Innovative Research, Novi, MI) were added in Hank's buffer, and cells were incubated at 37 °C for specified times. ...

  • Tags: Human Serum, Pooled Human Complement Serum

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Determination of tafenoquine in human plasma by dispersive liquid‐liquid microextraction
    Single Donor Human Plasma (Blood Derived) from Innovative Research was used in the foll...
    Read the Article
    Antimicrobial properties of amylose-fatty ammonium salt inclusion complexes
    Sheep Red Blood Cells Packed 100% from Innovative Research was used in the following st...
    Read the Article
    Dierential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression
    Single Donor Human Whole Blood from Innovative Research was used in the following study...
    Read the Article

    ← Older Post Newer Post →